Laurence Harewood

Use of PSMA PET/CT to Assess Treatment Response Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer (MPC)

Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, Patrick Bowden, Tony Costello, Laurence Harewood, Niall Corcoran, Phil Dundee, Justin Peters, Nathan Lawrentschuk, Andrew Troy, David Webb, Yee Chan, Andrew See, Shankar Siva, Declan Murphy, Michael S Hofman, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy

A Anton, Z Ballok, P Bowden, T Costello, L Harewood, N Corcoran, P Dundee, J Peters, N Lawrentschuk, A Troy, D Webb, Y Chan, A See, S Siva, D Murphy, MS Hofman, B Tran

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A Selth, Stephen Q Wong, Laura H Porter, Natalie Lister, David Pook, Carmel J Pezaro, David L Goode, Richard J Rebello, Ashlee K Clark, Melissa Papargiris, Jenna Van Gramberg, Adrienne R Hanson, Patricia Banks, Hong Wang, Birunthi Niranjan, Shivakumar Keerthikumar, Shelley Hedwards, et al.

Journal article  |  2018  |  European Urology

Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens

Liam Toner, Nathan Papa, Marlon Perera, Nikolas Katelaris, Mahesha Weerakoon, Kwang Chin, Laurence Harewood, Damien M Bolton, Nathan Lawrentschuk

Journal article  |  2017  |  World Journal of Urology

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

Ryan Stuchbery, Geoff Macintyre, Marek Cmero, Laurence M Harewood, Justin S Peters, Anthony J Costello, Christopher M Hovens, Niall M Corcoran

Journal article  |  2016  |  Oncotarget

Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?

Fairleigh Reeves, Christopher M Hovens, Laurence Harewood, Shane Battye, Justin S Peters, Anthony J Costello, Niall M Corcoran

Journal article  |  2015  |  Canadian Urological Association Journal

Assessing expression of MUC1 and ZAG protein biomarkers in prostate biopsies improves prediction of adverse pathology following radical prostatectomy

N Durrani, M Waldron, C Cherry, L Harewood, M Frydenberg, J Pedersen, J Mills

Journal article  |  2015  |  The Open Prostate Cancer Journal

Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer

James G Huang, John Pedersen, Matthew KH Hong, Laurence M Harewood, Justin Peters, Anthony J Costello, Chris M Hovens, Niall M Corcoran

Journal article  |  2013  |  BJU International

Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer

Nikhil Sapre, John Pedersen, Matthew K Hong, Laurence Harewood, Justin Peters, Anthony J Costello, Chris M Hovens, Niall M Corcoran

Journal article  |  2012  |  BJU International

Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer

John Mills, Alice Oliver, Justin C Sherwin, Mark Frydenberg, Justin S Peters, Anthony Costello, Laurence Harewood, Christopher Love, Nicholas Redgrave, Kenneth L van Golen, Michael Bailey, John Pedersen

Journal article  |  2012  |  Pathology

Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease

Niall M Corcoran, Chris M Hovens, Charles Metcalfe, Matthew KH Hong, John Pedersen, Rowan G Casey, Justin Peters, Laurence Harewood, S Larry Goldenberg, Anthony J Costello, Martin E Gleave

Journal article  |  2012  |  BJU International

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume

Niall M Corcoran, Rowan G Casey, Matthew KH Hong, John Pedersen, Stephen Connolly, Justin Peters, Laurence Harewood, Martin E Gleave, Anthony J Costello, Chris M Hovens, S Larry Goldenberg

Journal article  |  2012  |  BJU International

Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours

Niall M Corcoran, Chris M Hovens, Matthew KH Hong, John Pedersen, Rowan G Casey, Stephen Connolly, Justin Peters, Laurence Harewood, Martin E Gleave, S Larry Goldenberg, Anthony J Costello

Journal article  |  2012  |  BJU International

Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence

Niall M Corcoran, Matthew KH Hong, Rowan G Casey, Antonio Hurtado-Coll, Justin Peters, Laurence Harewood, S Larry Goldenberg, Chris M Hovens, Anthony J Costello, Martin E Gleave

Journal article  |  2011  |  BJU International

Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup

Matthew KH Hong, Benjamin Namdarian, Niall M Corcoran, John Pedersen, Declan G Murphy, Justin S Peters, Laurence Harewood, Nikhil Sapre, Kathryn Rzetelski-West, Anthony J Costello, Christopher M Hovens

Journal article  |  2011  |  Pathology

A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects

J Beilin, L Harewood, M Frydenberg, H Mameghan, RF Martyres, SJ Farish, C Yue, DR Deam, KA Byron, JD Zajac

Journal article  |  2001  |  Cancer